Advertisement HST Global signs LOI to acquire treatment facility - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

HST Global signs LOI to acquire treatment facility

HST Global, an integrated biotechnology health and wellness company, has signed a letter of intent to acquire a treatment facility. HST anticipates completing the acquisition of the center in the next 90 days.

According to HST, this acquisition will allow the company to provide alternative healthcare options for those who are suffering from late stage cancer.

Ron Howell, president and CEO of HST Global, said: “HST is excited to have completed the initial documentation necessary to initiate the acquisition of our first health and wellness center. As stated previously, the company intends to open three to five centers worldwide during 2009.”